GSK_ Annual_Report_2021-22

GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 48 2b. If the answer to Sr. No. 1 against any principle is ‘No’, please explain why: (Tick up to 2 options) Questions P1 P2 P3 P4 P5 P6 P7 P8 P9 The Company has not understood the principles N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. The Company is not at a stage where it finds itself in a position to formulate and implement the policies on specified principles N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. The Company does not have financial or manpower resources available for the task N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. It is planned to be done within the next six months N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. It is planned to be done within the next one year N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. Any other reason (please specify) N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. N.A. 3. Governance related to BR: The Board of Directors of the Company assesses business responsibility initiatives annually. The Company publishes a Business Responsibility Report in its Annual Report once a year which is available on our official website. Section E: Principle-wise performance Ethics, transparency and accountability Good governance and transparent reporting are a part of our commitment to be open about our business activities. Your Company has a strong value-based culture and its actions are supported by robust policies and compliance processes. It conducts business in an ethical way and engages stakeholders directly to understand and prioritise the issues that are important to them. As a global corporation, your Company has a GSK Code. This Code sets out fundamental standards for all employees and is supported by the written standards, which help employees make ethical decisions and emphasise the Company’s values. Your Company ensures that everything that it does is guided by its commitment to its values and regulations within which it must operate. The foundations of these commitments are laid out in the Company’s Code and each employee takes personal responsibility to abide by this Code. This Code also extends to anyone who works for and on behalf of your Company. Your Company markets prescription medicines and vaccines to healthcare professionals, hospitals, and the government. Our policies and the updated Code of Practice for Promotion of Prescription Medicines and for Scientific Engagement prescribe the nature of your Company’s practices. This Code, as the name suggests, is applicable worldwide. Regional and local policies, standard operating procedures, and other written standards provide additional guidance to employees. In addition, your Company is also a signatory to the Code of Pharmaceutical Practices of the Organisation of Pharmaceutical Producers of India (OPPI). Your Company has an extensive Anti-Bribery and Corruption (ABAC) Programme. ABAC is a part of your Company’s response to the threat and risk of bribery and corruption. The programme includes the ABAC Policy, which has been designed to assist internal and external parties, understand corruption risk, and identify people’s responsibilities to actively combat both real and perceived corruption. Safety and sustainability of products and services Sustainability in business is critically important to deliver continued innovation and success while reducing environmental impact. Your Company’s commercial success depends on growing a diverse business, creating innovative and efficient new products which people value, making them widely sought after. In the process, your Company can grow its business and add value to patients, consumers, employees, shareholders, and society. Through a wide range of products and services, your Company touches the lives of millions of patients every day. Your Company endeavours to work with responsible suppliers who adhere to the quality, social and environmental standards that are mandated. The interest of the patient is of prime importance at every stage in your Company - from development to final distribution. As a global organisation, most of your Company’s products are approved by major international regulators. Besides, there are mandatory regulatory approvals required in India, endorsing the safety of the products. A significant proportion of ingredients for your Company’s products and packaging material are sourced locally from third-party manufacturers belonging to micro, small and medium enterprises (MSMEs). A qualified team is in place to build capacity and capability, to educate and raise the standard of these vendors and as mentioned above, these vendors comply with your Company’s standards. To ensure the same, all vendors must go through the GSK audit and approval process, which are based on global guidelines. Your Company’s operational quality team trains and guides these vendors to ensure that they have the infrastructure, facilities, systems and controls in line with GSK’s global standards. In addition, periodic quality audits are held to ensure that the manufacturing processes, both internally as well as with contract manufacturing partners, remain compliant with your Company’s quality standards. These are over and above the specific quality checks with respect to each batch of finished products, as well as inputs in the form of raw materials. Annexure ‘B’ Business Responsibility (BR) Report